Respana Therapeutics, Inc
Respana Therapeutics, Inc is a biotech company in Philadelphia, United States, founded in 2018. It has raised $31.6M across 3 rounds, most recently a $20.0M Series B in March 2026.
Developer of Novel Therapeutics for the Treatment of Acute Respiratory Conditions
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- respanatx.com
- Total Funding
- $31.6M
- Last Round
- $20.0M Series BMar 2026
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds for this company. The full record is or through the API.
About
Respana Therapeutics is a preclinical-stage biopharmaceutical company developing host-directed therapeutics to modulate dysregulated immune responses following respiratory viral infections such as influenza, RSV, and coronavirus. The company's lead program is a monoclonal antibody candidate licensed from Penn State University, designed to address post-infectious pulmonary complications with validated preclinical survival data.
Summary
It lists 1–10 employees. It has raised $31.6M in total across 3 rounds, most recently a $20.0M Series B round in Mar 2026.
Funding History
Mar 2026
Sign up to see all 3 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/respana-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/respana-therapeutics-inc" alt="Respana Therapeutics, Inc on Indexed.vc" width="260" height="76" /></a>